These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21565674)

  • 1. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids.
    Ong SL; Whitworth JA
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):393-407, ix. PubMed ID: 21565674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired vasodilation and nitric oxide synthase activity in glucocorticoid-induced hypertension.
    Mitchell BM; Webb RC
    Biol Res Nurs; 2002 Jul; 4(1):16-21. PubMed ID: 12363278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension.
    Gkaliagkousi E; Douma S; Zamboulis C; Ferro A
    J Hypertens; 2009 Dec; 27(12):2310-20. PubMed ID: 19838132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
    Majid DS; Kopkan L
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-induced hemodynamic regulation mediated by nitric oxide.
    Toda N; Arakawa K
    J Hypertens; 2011 Mar; 29(3):415-24. PubMed ID: 21150639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension.
    Beltowski J; Wójcicka G; Marciniak A; Jamroz A
    Life Sci; 2004 Apr; 74(24):2987-3000. PubMed ID: 15051422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress.
    Kimura Y; Hirooka Y; Sagara Y; Ito K; Kishi T; Shimokawa H; Takeshita A; Sunagawa K
    Circ Res; 2005 Feb; 96(2):252-60. PubMed ID: 15591232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells.
    Aljofan M; Ding H
    J Cell Physiol; 2010 Mar; 222(3):669-75. PubMed ID: 19950211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and cardiovascular risk factors.
    Strohmayer EA; Krakoff LR
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction.
    Kumagai Y; Pi J
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):450-7. PubMed ID: 15276426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt and nitric oxide inhibition induced hypertension: the role of prostacycline and 8-isoprostane.
    Ilhan S; Oktar S; Sahna E; Aksulu HE
    Clin Exp Hypertens; 2011; 33(2):84-8. PubMed ID: 21214402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion.
    White WB; Pepine CJ; Weber MA
    Am J Med; 2009 May; 122(5 Suppl):S23-5. PubMed ID: 19393823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endothelial function].
    Higashi Y; Yoshizumi M
    Nihon Rinsho; 2003 Jul; 61(7):1138-44. PubMed ID: 12877075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension secondary to Cushing syndrome].
    Tanabe A; Naruse M; Takano K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():526-30. PubMed ID: 15171429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.